United States · Venture startup

Who invested in Response Pharmaceuticals

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$3.9Mraised across 1 round since 2024, from 1 source

Latest round
Venture, $3.9MJun 2024
Investors
0
See who backed them

The rounds

  1. Jun 2024
    Venture$3.9M

    No investor was named in the report.

    Source recordedSEC filing: $3.9M sold, first sale Jun 2024

Founders and team

From the SEC filings it signed: 1 on the team.

  • Eric KellerExecutive Officer, Directori

On the board, as filediDonald OldsMichael Berendt

Also claim to have backed them

This firm lists Response Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

K2X CapitalVC firmPer its own site

Quick answers about Response Pharmaceuticals

How much has Response Pharmaceuticals raised?

Response Pharmaceuticals has raised $3.9M across 1 round since 2024.

When did Response Pharmaceuticals last raise?

Response Pharmaceuticals's most recent round was a Venture of $3.9M in Jun 2024.

What was Response Pharmaceuticals's biggest round?

Its most recent round, $3.9M in Jun 2024, is also its largest on record.

What stage is Response Pharmaceuticals at?

Response Pharmaceuticals's latest named round is a Venture, in Jun 2024.

Where is Response Pharmaceuticals based?

Response Pharmaceuticals is based in the United States.

Companies like Response Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.